WINSTON-SALEM, N.C. — Inmar Intelligence announced the appointment of Brian Nightengale as executive vice president and president, Healthcare Solutions. He brings a wealth of expertise spanning the pharmaceutical supply chain, clinical care, and strategic commercialization, that will serve as a critical addition to Inmar Intelligence’s health care leadership team.

Brian Nightengale

Nightengale has over 30 years of experience in the health care and pharmaceutical industry and was the president of Community Retail & Long-Term Care for Cencora (formerly AmerisourceBergen Corp). In this role, he was responsible for the company’s independent community pharmacy and long-term care segments, including the Good Neighbor Pharmacy and Elevate Provider Network Programs and SmartSource, Cencora’s secondary wholesale brand. He is the immediate past chair of the National Association of Chain Drug Stores.

Prior to his current position, Brian was senior vice president of Community & Specialty Pharmacy and president of Good Neighbor Pharmacy. More than 5,000 independent pharmacies rely on Good Neighbor Pharmacy and Elevate Provider Network for solutions and guidance to elevate, optimize and expand their businesses so they can maintain their status as preferred health care destinations in their communities. He joined the company in 2016.

His extensive background will play a pivotal role in advancing Inmar Intelligence’s mission to drive safety, create operational efficiencies, and demonstrate value to stakeholders throughout the healthcare supply chain. With a foundation as a pharmacist, he has worked across multiple healthcare settings, including chain and independent retail, long-term care, health systems, and nuclear pharmacies. He then dedicated two decades to collaborating closely with pharmaceutical manufacturers, devising data-driven commercialization strategies for their groundbreaking products. In his most recent role, he spent seven years in wholesale distribution, supporting pharmacies with a comprehensive suite of products and financial solutions to enhance their operational efficiency and growth.

“I am honored to join Inmar Intelligence and I am very excited to work with the team to invent new ways to create even more value for our customers,” says Nightengale. “With a unique background in healthcare and a deep understanding of the pharmaceutical supply chain, I look forward to helping Inmar continue to accelerate its growth and deepen its commitment to improving patient outcomes.”

Spencer Baird, CEO of Inmar Intelligence, shared his enthusiasm for the new addition, saying, “Brian’s extensive background is a valuable asset to our team. We are confident that his leadership will further strengthen our position in the healthcare sector, allowing us to continue providing innovative solutions and fostering a safer healthcare ecosystem.”

“Inmar Intelligence’s commitment to health care innovation has been evident through its strategic partnerships and advancements in pharmaceutical supply chain management, particularly in relation to the Drug Supply Chain Security Act (DSCSA) and USP <800> regulations. Brian Nightengale’s appointment and expertise will play a pivotal role in advancing these initiatives,” Baird adds.